USA 1-800-227-2862 (BBRAUN2)
U.S.A.
 
Home > Press > Company News

Company News

   

Read news and press releases about B. Braun Medical Inc. (B.Braun), covering subjects ranging from products, related events, company news and more.

05/24/2012

B. Braun Brings Advancements in Safety and Education to APIC

Safety Engineered Products and Best Practices Will Be Featured in B. Braun-Sponsored Breakfast Symposia

Bethlehem, Pa. – May 24, 2012 – B. Braun Medical Inc. (B. Braun) will be attending APIC  2012 from June 4 through 6 in San Antonio, Texas displaying a range of safety-engineered devices designed to advance protection from infection in the healthcare setting for both patients and healthcare workers. The company’s new Introcan Safety® 3 Closed IV Catheter will be in the spotlight, directly addressing issues pertaining to exposure to blood borne pathogens and catheter related complications. Like B. Braun’s existing Introcan Safety IV Catheter, the next generation Introcan Safety 3 includes passive safety protection1  from needlestick injuries, with the addition of an innovative multi-access blood control septum to aid in the prevention of blood exposure each time the device is accessed. An integrated stabilization platform is designed to improve catheter stability and minimize movement in the vein, which could help reduce catheter-related complications. Introcan Safety 3 Closed IV Catheter will be available for widespread distribution in July 2012.

Other safety innovations to be displayed include the CARESITE® needleless connector and ULTRAPORT™ zerO 4-way stopcock, both designed to reduce potential for contamination, improve patient care and increase clinician convenience. The broad line of B. Braun peripheral IV catheters, infusion systems, needleless connectors, stopcocks, and accessory kits that focus on safety in the healthcare setting will be demonstrated at Booth 501. 

 “B. Braun is committed to providing products that address the critical issues of infection prevention and healthcare worker and patient safety. Our new Introcan Safety 3 Closed IV Catheter is the latest example of B. Braun’s continuous efforts to expand our product offering with designs intended to protect both clinicians and patients from healthcare acquired infections,” said Tom Sutton, B. Braun’s Vice President of Marketing, Vascular Access and IV Systems. “Sharing our knowledge and expertise of products and best practice is the most important thing we can do at APIC for clinicians, infection control professionals and administrators.” 

B. Braun is hosting two Satellite Education symposia during APIC 2012 that focus on increased infection control and safety in the healthcare setting. On Monday, June 4, 2012 from 6:00 AM to 7:30 AM the subject of “Intraoperative Infection Control: A Paradigm Shift” will be presented by Dr.  Randy W. Loftus, MD, Assistant Professor of Anesthesiology, Dartmouth Hitchcock Medical Center and Dr. Matthew D. Koff, MD, MS, Assistant Professor of Anesthesiology, Dartmouth Hitchcock Medical Center, at the San Antonio Convention Center, Room 006 A & B. 

Lynn Hadaway, M.Ed, RN, BC, CRNI will be featured in a symposium entitled “Mucocutaneous Blood Exposure and Peripheral Catheters – Acknowledging the Risk, Documenting Occurrences” on Wednesday, June 6, 2012 from 6:00 AM to 7:30 AM at the San Antonio Convention Center, Room 008.  Ms. Hadaway, the President of Lynn Hadaway Associate, Inc., and over 35 years of experience in infusion nursing and adult education will be followed by a presentation on new product technology by B. Braun’s Tom Sutton.  A continental breakfast will be served to attendees of both symposia. 

About B. Braun

B. Braun is a leading manufacturer of infusion therapy and pain management products with an environmentally-friendly focus. Guided by the company’s “Sharing Expertise®” philosophy, B. Braun addresses the critical issues of infection prevention, medication safety and environmental responsibility by promoting best practices that help clinicians reduce medication errors, prevent healthcare-acquired infections (HAIs) and achieve sustainability objectives.

Consistently recognized by Frost & Sullivan and KLAS for its medical technology and support services, B. Braun employees share their knowledge with colleagues and customers to improve working processes in hospitals and medical practices and to enhance the safety of patients and healthcare professionals. For more information, call 800-227-2862, email us at inquiry.us@bbraun.com or visit B. Braun at www.bbraunusa.com.


 

 

 

Reference:

 1Needlestick Injury Rates According to Different Types of Safety-Engineered Devices: Results of a French Multicenter Study conducted by GERES (Groupe d'Etude sur le Risque d'Exposition des Soignants aux Agents Infectieux), and published by Infection Control and Hospital Epidemiology, April 2010; 31:402-407